{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:42:55Z","timestamp":1775184175156,"version":"3.50.1"},"reference-count":27,"publisher":"Walter de Gruyter GmbH","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jaoa.2020.052_s_001_w2aab3b7c13b1b6b1aab1c16b1Aa\">\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Inflammatory bowel disease (IBD), such as ulcerative colitis and Crohn disease, are chronic relapsing inflammatory diseases that affect 1.5 million people in the United States. Lymphatic pump treatment (LPT) techniques were designed to enhance the movement of lymph and can be used to relieve symptoms in patients with IBD and other gastrointestinal disorders.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jaoa.2020.052_s_002_w2aab3b7c13b1b6b1aab1c16b2Aa\">\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To determine whether LPT would decrease gastrointestinal inflammation and reduce disease severity in rats with acute IBD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jaoa.2020.052_s_003_w2aab3b7c13b1b6b1aab1c16b3Aa\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>On day 0, rats were randomized into control or experimental groups. Control rats received normal drinking water for days 0 to 9. On days 0 to 9, rats in the experimental groups received drinking water containing 3.5% dextran sodium sulfate (DSS). On day 3, experimental rats were randomized into 3 groups. On days 3 to 8, experimental rats received either (1) no treatment or anesthesia (DSS alone); (2) 4 minutes of LPT with anesthesia administration (DSS+LPT); or (3) 4 minutes of sham treatment (ie, light touch) and anesthesia (DSS+sham). On day 9, colons and gastrointestinal lymphoid tissue were collected. Colon weight, histologic changes, disease activity index (DAI) score, and the concentration of leukocytes were measured.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jaoa.2020.052_s_004_w2aab3b7c13b1b6b1aab1c16b4Aa\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>At day 9, the mean (SD) DAI score in the DSS+LPT group (1.0 [0.1]) was significantly decreased (<jats:italic>P<\/jats:italic>&lt;.01) compared with the DAI score of DSS-alone rats (1.5 [0.1]). While the DAI in DSS+LPT rats was reduced on days 8 to 9, this difference was not statistically different (<jats:italic>P<\/jats:italic>&gt;.05) compared with DSS+sham (1.3 [0.1]). No significant differences were found in colon weight, histopathologic findings, or the concentration of gastrointestinal leukocytes between DSS alone, DSS+sham, or DSS+LPT (<jats:italic>P<\/jats:italic>&gt;.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jaoa.2020.052_s_005_w2aab3b7c13b1b6b1aab1c16b5Aa\">\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>While DSS+LPT reduced IBD compared with DSS+sham, the decrease was not statistically significant. Considering the growing use of adjunctive treatment for the management of IBD, it is important to identify the effect of osteopathic manipulative medicine on IBD progression.<\/jats:p>\n               <\/jats:sec>","DOI":"10.7556\/jaoa.2020.052","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T05:30:38Z","timestamp":1587965438000},"page":"337-344","source":"Crossref","is-referenced-by-count":4,"title":["Effect of Abdominal Lymphatic Pump Treatment on Disease Activity in a Rat Model of Inflammatory Bowel Disease"],"prefix":"10.1515","volume":"120","author":[{"given":"Artur","family":"Schander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudy","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dante","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2020,5,1]]},"reference":[{"issue":"6","key":"2021042107255995925_j_jaoa.2020.052_ref_001_w2aab3b7c13b1b6b1ab2ab1Aa","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.suc.2015.07.006","article-title":"Inflammatory bowel disease: historical perspective, epidemiology, and risk factors","volume":"95","year":"2015","journal-title":"Surg Clin North Am"},{"issue":"5","key":"2021042107255995925_j_jaoa.2020.052_ref_002_w2aab3b7c13b1b6b1ab2ab2Aa","doi-asserted-by":"publisher","first-page":"S970","DOI":"10.1016\/S0016-5085(17)33292-4","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"152","year":"2017","journal-title":"Gastroenterology"},{"issue":"9","key":"2021042107255995925_j_jaoa.2020.052_ref_003_w2aab3b7c13b1b6b1ab2ab3Aa","doi-asserted-by":"publisher","first-page":"695","DOI":"10.7556\/jaoa.2014.139","article-title":"Osteopathic primary care of patients with inflammatory bowel disease: a review","volume":"114","year":"2014","journal-title":"J Am Osteopath Assoc"},{"key":"2021042107255995925_j_jaoa.2020.052_ref_004_w2aab3b7c13b1b6b1ab2ab4Aa","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1111\/j.1749-6632.2010.05757.x","article-title":"Emerging roles of lymphatics in inflammatory bowel disease","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"2021042107255995925_j_jaoa.2020.052_ref_005_w2aab3b7c13b1b6b1ab2ab5Aa","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.aanat.2018.03.006","article-title":"Mesenteric organ lymphatics and inflammatory bowel disease","volume":"218","year":"2018","journal-title":"Ann Anat"},{"issue":"10","key":"2021042107255995925_j_jaoa.2020.052_ref_006_w2aab3b7c13b1b6b1ab2ab6Aa","first-page":"457","article-title":"Manual techniques addressing the lymphatic system: origins and development","volume":"105","year":"2005","journal-title":"J Am Osteopath Assoc"},{"key":"2021042107255995925_j_jaoa.2020.052_ref_007_w2aab3b7c13b1b6b1ab2ab7Aa","first-page":"799","article-title":"Lymphatics approach","volume-title":"Foundations of Osteopathic Medicine","year":"2011","edition":"3rd"},{"key":"2021042107255995925_j_jaoa.2020.052_ref_008_w2aab3b7c13b1b6b1ab2ab8Aa","first-page":"751","article-title":"The abdominal region.","volume-title":"Foundations for Osteopathic Medicine","year":"2003"},{"issue":"8","key":"2021042107255995925_j_jaoa.2020.052_ref_009_w2aab3b7c13b1b6b1ab2ab9Aa","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/MEG.0b013e3283543eb7","article-title":"Osteopathy improves the severity of irritable bowel syndrome: a pilot randomized sham-controlled study","volume":"24","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"12","key":"2021042107255995925_j_jaoa.2020.052_ref_010_w2aab3b7c13b1b6b1ab2ac10Aa","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/1751-2980.12098","article-title":"Treatment of refractory irritable bowel syndrome with visceral osteopathy: short-term and long-term results of a randomized trial","volume":"14","year":"2013","journal-title":"J Dig Dis"},{"key":"2021042107255995925_j_jaoa.2020.052_ref_011_w2aab3b7c13b1b6b1ab2ac11Aa","doi-asserted-by":"publisher","first-page":"470","DOI":"10.7556\/jaoa.2014.098","article-title":"Effectiveness of osteopathic manipulative therapy for managing symptoms of irritable bowel syndrome: a systematic review","volume":"114","year":"2014","journal-title":"J Am Osteopath Assoc"},{"issue":"51","key":"2021042107255995925_j_jaoa.2020.052_ref_012_w2aab3b7c13b1b6b1ab2ac12Aa","doi-asserted-by":"publisher","first-page":"e13811","DOI":"10.1097\/MD.0000000000013811","article-title":"Effect of the soft-tissue techniques in the quality of life in patients with Crohn's disease: a randomized controlled trial","volume":"97","year":"2018","journal-title":"Medicine (Baltimore"},{"key":"2021042107255995925_j_jaoa.2020.052_ref_013_w2aab3b7c13b1b6b1ab2ac13Aa","first-page":"22","article-title":"Crohn's disease: a case report including the most recent theories and treatment principles","year":"2006","journal-title":"AAOJ"},{"issue":"4","key":"2021042107255995925_j_jaoa.2020.052_ref_014_w2aab3b7c13b1b6b1ab2ac14Aa","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1089\/lrb.2012.0021","article-title":"Lymphatic pump treatment repeatedly enhances the lymphatic and immune systems","volume":"11","year":"2013","journal-title":"Lymphat Res Biol"},{"issue":"2","key":"2021042107255995925_j_jaoa.2020.052_ref_015_w2aab3b7c13b1b6b1ab2ac15Aa","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1089\/lrb.2009.0011","article-title":"Abdominal lymphatic pump treatment mobilizes leukocytes from the gastrointestinal associated lymphoid tissue into lymph","volume":"8","year":"2010","journal-title":"Lymphat Res Biol"},{"issue":"1","key":"2021042107255995925_j_jaoa.2020.052_ref_016_w2aab3b7c13b1b6b1ab2ac16Aa","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1258\/ebm.2011.011220","article-title":"Lymphatic pump manipulation mobilizes inflammatory mediators into lymphatic circulation","volume":"237","year":"2012","journal-title":"Exp Biol Med"},{"issue":"7","key":"2021042107255995925_j_jaoa.2020.052_ref_017_w2aab3b7c13b1b6b1ab2ac17Aa","doi-asserted-by":"publisher","first-page":"455","DOI":"10.7556\/jaoa.2018.099","article-title":"Lymphatic pump technique mobilizes bioactive lymph that suppresses macrophage activity in vitro","volume":"118","year":"2018","journal-title":"J Am Osteopath Assoc"},{"issue":"4","key":"2021042107255995925_j_jaoa.2020.052_ref_018_w2aab3b7c13b1b6b1ab2ac18Aa","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1089\/lrb.2010.0009","article-title":"Lymphatic pump treatment augments the lymphatic flux of lymphocytes in rats","volume":"8","year":"2010","journal-title":"Lymphat Res Biol"},{"issue":"5","key":"2021042107255995925_j_jaoa.2020.052_ref_019_w2aab3b7c13b1b6b1ab2ac19Aa","first-page":"306","article-title":"King HH","volume":"115","year":"2015","journal-title":"Lymphatic pump treatment as an adjunct to antibiotics for pneumonia in a rat model [published correction appears in"},{"issue":"33","key":"2021042107255995925_j_jaoa.2020.052_ref_020_w2aab3b7c13b1b6b1ab2ac20Aa","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.3748\/wjg.v23.i33.6016","article-title":"Dextran sodium sulfate colitis murine model: an indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis","volume":"23","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"2","key":"2021042107255995925_j_jaoa.2020.052_ref_021_w2aab3b7c13b1b6b1ab2ac21Aa","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.vascn.2003.12.002","article-title":"Animal models of inflammatory bowel disease","volume":"50","year":"2004","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"7","key":"2021042107255995925_j_jaoa.2020.052_ref_022_w2aab3b7c13b1b6b1ab2ac22Aa","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1023\/a:1026620322859","article-title":"Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects","volume":"44","year":"1999","journal-title":"Dig Dis Sci"},{"key":"2021042107255995925_j_jaoa.2020.052_ref_023_w2aab3b7c13b1b6b1ab2ac23Aa","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/710856","article-title":"Examination of the anti-inflammatory, antioxidant, and xenobiotic-inducing potential of broccoli extract and various essential oils during a mild DSS-induced colitis in rats","year":"2015","journal-title":"ISRN Gastroenterol"},{"issue":"4","key":"2021042107255995925_j_jaoa.2020.052_ref_024_w2aab3b7c13b1b6b1ab2ac24Aa","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/00365521.2019.1595708","article-title":"Roseburia intestinalis inhibits oncostatin M and maintains tight junction integrity in a murine model of acute experimental colitis","volume":"54","year":"2019","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"2021042107255995925_j_jaoa.2020.052_ref_025_w2aab3b7c13b1b6b1ab2ac25Aa","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/labinvest.2015.32","article-title":"Recombinant human MFG-E8 ameliorates colon damage in DSS- and TNBS-induced colitis in mice","volume":"95","year":"2015","journal-title":"Lab Invest"},{"key":"2021042107255995925_j_jaoa.2020.052_ref_026_w2aab3b7c13b1b6b1ab2ac26Aa","article-title":"Guide for the Care and Use of Laboratory Animals","edition":"8th"},{"key":"2021042107255995925_j_jaoa.2020.052_ref_027_w2aab3b7c13b1b6b1ab2ac27Aa","year":"2013"}],"container-title":["Journal of Osteopathic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.7556\/jaoa.2020.052\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.7556\/jaoa.2020.052\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T13:48:21Z","timestamp":1619185701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.7556\/jaoa.2020.052\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,1]]},"published-print":{"date-parts":[[2020,5,1]]}},"alternative-id":["10.7556\/jaoa.2020.052"],"URL":"https:\/\/doi.org\/10.7556\/jaoa.2020.052","relation":{},"ISSN":["2702-3648"],"issn-type":[{"value":"2702-3648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}